In patients hospitalised with acute heart failure, nesiritide, compared with placebo, is not associated with improvements in dyspnoea or 30-day rehospitalisation or mortality.
Evid Based Med. 2011 Sep 26;
Authors: Salzberg SP
PMID: 21949253 [PubMed - as supplied by publisher]